Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial-Reference-Cited by-同舟云学术

Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial

Published:2022-12 Issue: Volume:30 Page:101025
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Lang Jason E.^ORCID,Hornik Chi D.^ORCID,Martz Karen,Jacangelo Juliana,Anand Ravinder,Greenberg Rachel,Hornik Christoph,Zimmerman Kanecia,Smith P. Brian,Benjamin Daniel K.,Laughon Matthew

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference33 articles.

1. Bronchopulmonary dysplasia;Thebaud;Nat. Rev. Dis. Prim.,2019

2. Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery?;Wadhawan;Am. J. Obstet. Gynecol.,2003

3. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program;Poindexter;Ann Am Thorac Soc,2015

4. Severity of bronchopulmonary dysplasia among very preterm infants in the United States;Jensen;Pediatrics,2021

5. Early cumulative supplemental oxygen predicts bronchopulmonary dysplasia in high risk extremely low gestational age newborns;Wai;J. Pediatr.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia;Journal of Clinical Medicine;2024-06-11

2. Prophylactic sildenafil to prevent bronchopulmonary dysplasia: A systematic review and meta‐analysis;Pediatrics International;2024-01

3. Targeted Therapies for Neonatal Pulmonary Hypertension: Beyond Nitric Oxide;Clinics in Perinatology;2023-12

4. Early Pulmonary Hypertension in Preterm Infants;Clinics in Perinatology;2023-12